Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA2A | P08913 | 9/20 | 1.00 |
| ▸ | ADRA1A | P35348 | 8/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 7/20 | 1.00 |
| ▸ | ADRA2C | P18825 | 6/20 | 1.00 |
| ▸ | ADRA2B | P18089 | 5/20 | 1.00 |
| ▸ | ADRA1B | P35368 | 4/20 | 1.00 |
| ▸ | MEN1 | O00255 | 3/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 3/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 3/20 | 1.00 |
| ▸ | ADRA1D | P25100 | 3/20 | 1.00 |
| ▸ | PMP22 | Q01453 | 3/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 1.00 |
| ▸ | LMNA | P02545 | 2/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 2/20 | 1.00 |
| ▸ | TSHR | P16473 | 2/20 | 1.00 |
| ▸ | HTR1A | P08908 | 2/20 | 1.00 |
| ▸ | THRB | P10828 | 2/20 | 1.00 |
| ▸ | HPGD | P15428 | 2/20 | 1.00 |
| ▸ | HTR1B | P28222 | 2/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Rauwolscine SCHEMBL4548294 | 1.00 | ADRA2A (1.00) | ADRA2AADRA1ACYP2D6ADRA2CADRA2B | |
| Rauwolscine SCHEMBL8366111 | 1.00 | ADRA2A (1.00) | ADRA2AADRA1ACYP2D6ADRA2CADRA2B | |
| Rauwolscine SCHEMBL7945869 | 1.00 | ADRA2A (1.00) | ADRA2AADRA1ACYP2D6ADRA2CADRA2B | |
| Rauwolscine SCHEMBL25366080 | 1.00 | ADRA2A (1.00) | ADRA2AADRA1ACYP2D6ADRA2CADRA2B | |
| Rauwolscine SCHEMBL6700479 | 1.00 | ADRA2A (1.00) | ADRA2AADRA1ACYP2D6ADRA2CADRA2B | |
| Rauwolscine SCHEMBL23244673 | 1.00 | ADRA2A (1.00) | ADRA2AADRA1ACYP2D6ADRA2CADRA2B | |
| Rauwolscine SCHEMBL564021 | 1.00 | ADRA2A (1.00) | ADRA2AADRA1ACYP2D6ADRA2CADRA2B | |
| Rauwolscine SCHEMBL18541713 | 1.00 | ADRA2A (1.00) | ADRA2AADRA1ACYP2D6ADRA2CADRA2B | |
| Rauwolscine SCHEMBL22703462 | 1.00 | ADRA2A (1.00) | ADRA2AADRA1ACYP2D6ADRA2CADRA2B | |
| Rauwolscine SCHEMBL244514 | 1.00 | ADRA2A (1.00) | ADRA2AADRA1ACYP2D6ADRA2CADRA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8569481-B2 | Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions | PHARMACEUTICALS, INC. (US) | 2013-10-29 | — | — | US | disclosed |
| US-20110118136-A1 | Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions | KOESTER HUBERT | 2011-05-19 | — | — | US | disclosed |
| US-20100298168-A1 | Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions | HK PHARMACEUTICALS, INC. | 2010-11-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110118136-A1 | Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions | PTMS, QPCTL, SRMS | ADRA2A 4813/4885ADRA1A 4831/4885CYP2D6 4323/4885 |
| US-20100298168-A1 | Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions | CHLSN, PTMS, SRMS | ADRA2A 4862/4885ADRA1A 4863/4885CYP2D6 4202/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.